Preparing the published article.
Company Profile: CMR Surgical and Versius
An official-source profile of CMR Surgical's Versius and Versius Plus systems, covering modular design, digital tools, dated activity, market-specific product limits and hospital procurement questions.
1. Company focus and institutional users
CMR Surgical is a medical-device company founded in 2014 and headquartered in Cambridge, United Kingdom. It develops the Versius family for robotic minimal access surgery and works with surgeons, operating-room teams and hospitals. Its published commercial model combines surgical equipment with training and digital tools. A useful buyer assessment therefore covers both the device and the hospital programme needed to operate it. Official company and product background.
2. Versius and the modular surgical model
CMR presents Versius as a small, modular and portable surgical robot designed around familiar laparoscopic port placement. These are design characteristics described by the manufacturer. Room compatibility, staff access and the practical movement of equipment still need a site assessment; promotional descriptions do not replace an installation plan. Versius overview.
The FDA description of Versius Plus identifies an open surgeon console, a visualization bedside unit, instrument bedside units, surgical attachments, cables and sterile drapes. Surgeons operate controls at the console, while the bedside team has separate controls and feedback. The system assists trained clinical teams; it should not be presented as autonomous surgery. FDA device description.
3. Versius Plus and market-specific product boundaries
CMR calls Versius Plus its second-generation platform and distinguishes it from first-generation Versius, which received US De Novo marketing authorization in October 2024. Plus adds developments including integrated fluorescence visualization. A quotation should state the exact generation, imaging equipment and instrument set. Manufacturer's generation comparison.
The FDA's K252111 decision is dated 16 December 2025. Its US indication covers cholecystectomy in patients aged 22 and older who are eligible for soft-tissue minimal access surgery. This specific clearance does not authorize every procedure described in international case reports. FDA clearance and indications.
At review, CMR's US site describes a benign-gynecology submission as pending, says the Ultrasonic Dissector is not approved for US sale, and notes that ICG is sourced separately. Availability must be checked by geography and component. US product information and limitations.
4. Digital tools and the information workflow
CMR's digital ecosystem combines robotic telemetry, procedure video and clinical context from the CMR Registry. Versius Connect gives surgeons a case logbook, statistics, video and instrument timelines. Versius Team provides access to previous setups and live case reporting to support the surgical team. These are supplier-described information functions, not proof that software will improve a particular patient's result. Digital ecosystem description.
A hospital evaluating these services should ask which applications are included, who can access recordings, where information is hosted, how records are exported and how access ends when a contract expires. Confirm integration and data responsibilities in writing before treating a dashboard demonstration as a deployable hospital workflow.
5. Training and implementation planning
CMR describes a seven-step training pathway for surgeons and surgical teams, using competency metrics and observational assessment. Listed tools include Versius Trainer, eLearning and virtual-reality training. The published pathway supports a discussion about learning resources; it does not establish individual professional credentials or a hospital's permission to perform a procedure. Training within the digital ecosystem.
For an implementation proposal, ask CMR and the hospital's clinical leads to define training responsibilities, case-selection governance, bedside staffing, instrument processing, system checks and escalation arrangements. Request an acceptance plan that includes installation, supervised familiarization and support contacts. These are procurement questions, not additional features assumed to be supplied with every system.
6. Dated use and international expansion evidence
CMR's international homepage lists a feature dated 30 March 2023 about teams working with Versius at Milton Keynes University Hospital. It is a concrete, supplier-documented UK hospital example. It should be read as evidence of the reported programme at that date, without carrying over its experience to another hospital or to Versius Plus. Official feature listing.
The US homepage lists a 26 March 2026 announcement reporting more than 45,000 patients treated worldwide using Versius, alongside the company's US debut. This is a dated manufacturer aggregate across its reported global experience, not a count of US Plus cases, independent clinical evidence or a current installation directory. Dated US news listing.
7. International procurement and commercial contact
CMR's contact page provides an inquiry form, Cambridge headquarters details and regional locations, including offices in Italy, France, Brazil and Spain. Use that directory to identify the responsible team for the intended installation country. A listed office is a contact route and does not establish that every device configuration is available locally. Official contact directory.
Request a proposal covering the precise model, local indication, visualization and energy components, reusable-instrument limits, consumables, maintenance, training, digital services, lead time and contract terms. Compare the total programme scope rather than assuming a public price or universal service package. Ask for current country-specific labeling and local support commitments.
8. Source limits and related resources
Reviewed on 10 September 2026. Manufacturer pages describe products and reported activity; the FDA letter anchors one US device clearance. Neither source type alone establishes comparative clinical benefit, a treatment recommendation or guaranteed outcomes. Several CMR country links redirect between international and US pages, so verify the market shown and obtain the applicable instructions before relying on a specification.
Explore medical robotics, Write a Robotics Buyer Brief and Robotics RFQ.